@inproceedings{inproceedings, title  = {{ABC-06 vertical bar A randomised phase III study of Active Symptom Control (ASC) with/without mFOLFOX after progression to Cisplatin-Gemcitabine chemotherapy for patients with advanced biliary tract cancers}},

 url = {{}},

 year = {{2019}},

 month = {{1}},

 author = {{Lamarca A and Palmer DH and Wasan HS and Ross PJ and Ma YT and Arora A and Falk S and Gillmore R and Wadsley J and Patel K and Anthoney A et al}},

 volume = {{121}},

 journal = {{BRITISH JOURNAL OF CANCER}},

 pages = {{19-19}},

 note = {{Accessed on 2025/05/21}}}